Peking University Cancer Hospital
Why choose this hospital
Multidisciplinary Team (MDT)
One of the first pilot hospitals in China for oncology MDT, providing comprehensive one-stop solutions for complex cases.
Precision Medicine
Authorized as one of the first national clinical pilot sites for high-throughput cancer gene sequencing, offering targeted and immunotherapy.
Minimally Invasive Surgery
International leader in laparoscopic minimally invasive techniques for gastric, colorectal, and other cancers.
Reviews
Overall rating
Recommendation rate
30 patients
Care quality
Average score
【Disease: Cervical Cancer】【Purpose: Radical Hysterectomy】【Outcome: Very Satisfied】 The environment in the gynecologic oncology ward is excellent. The Chief Physician is highly skilled, utilizing minimally invasive laparoscopic techniques to perform a thorough dissection of the lesions and lymph nodes. Postoperative recovery was rapid, with no complications such as urinary retention. The medical team not only provided effective treatment but also prioritized psychological support. This is an outstanding medical team.
Compare advantages
Cost comparison
Significant savings on treatment costs
Clear package pricing with no hidden fees
Get detailed quoteWait time comparison
Faster access to treatment
About the hospital
Established in 1976, Peking University Cancer Hospital (Beijing Cancer Hospital) is a national Class A tertiary specialty hospital and a key component of the National Clinical Research Center for Cancer. The hospital maintains leading national and advanced international standards in the comprehensive diagnosis and treatment of gastric cancer, breast cancer, colorectal cancer, and melanoma. As one of China's first pilot units for multidisciplinary team (MDT) clinics, the hospital promotes standardized, individualized, and precision medicine. Its gastric cancer prevention and treatment system has received the Second Prize of the National Science and Technology Progress Award.
Top specialties
National Key Discipline and a recognized center for lymphoma diagnosis and research in China.
The Department of Lymphoma at Peking University Cancer Hospital is a leading center for the diagnosis and treatment of lymphoid malignancies in China. Integrating clinical care, research, and education, the department is dedicated to research on standardized, individualized, and targeted therapies for lymphoma.
National Clinical Key Specialty
The department is a recognized center for thoracic surgical oncology in China, known for its emphasis on anatomical precision and bloodless surgical techniques. It specializes in the standardized and minimally invasive treatment of lung cancer, esophageal cancer, and mediastinal tumors. It is recognized for its advanced capabilities in complex procedures, including tracheal sleeve resection and reconstruction, vascular replacement, and carinal resection and reconstruction. The department also operates an established multidisciplinary team (MDT) system.
Consistently ranks highly in the Fudan University China Hospital Specialist Reputation Ranking.
A comprehensive diagnosis, treatment, and translational research platform for gastrointestinal tumors in China, specializing in minimally invasive surgery, function preservation, and multidisciplinary precision targeted therapy for gastric and colorectal cancers.
Key Discipline of the Beijing Municipal Administration of Traditional Chinese Medicine
This department is a recognized center for integrative oncology in China, encompassing clinical care, medical education, and research. It specializes in combining modern and traditional medicine. Tailored to the physiological characteristics of elderly oncology patients, the department provides individualized comprehensive treatment, palliative care, and full-process rehabilitation management. The primary focus is on mitigating treatment-related side effects and improving patients' quality of life.
Key Discipline and Key Specialty of the National Administration of Traditional Chinese Medicine
Focuses on integrative Chinese and Western medicine treatment for malignant tumors and comprehensive geriatric oncology assessments. It holds a leading position in China in mitigating the toxic and side effects of radiotherapy and chemotherapy, managing adverse reactions to targeted therapies, and providing palliative cancer rehabilitation. The department specializes in utilizing traditional Chinese medicine to improve patients' quality of life and provides individualized, whole-course disease management.
Beijing Municipal Key Discipline and National Key Clinical Specialty
As a major center for breast oncology in China, the facility integrates early diagnosis, minimally invasive and reconstructive surgery, and systemic comprehensive treatment. It employs advanced techniques in breast-conserving surgery, precision targeted therapy, and sentinel lymph node biopsy, and is dedicated to providing standardized, individualized, and lifelong care management for patients in China.
A pioneer and leading institution in interventional ultrasound therapy for oncology in China
The Ultrasound Diagnosis Center at Peking University Cancer Hospital pioneered ultrasound-guided tumor ablation therapy in China. It maintains an advanced position in contrast-enhanced ultrasound for oncology, interventional ultrasound, and superficial organ ultrasound diagnostics, serving as a comprehensive interventional ultrasound center that integrates clinical care, education, and research.
National Key Discipline, Beijing Municipal Key Discipline, Chair Unit of the Gastric Cancer Professional Committee of the Chinese Anti-Cancer Association
The Gastric Cancer Prevention and Treatment Center (Gastrointestinal Oncology Center) at Peking University Cancer Hospital is a major center for gastric cancer diagnosis and treatment in China. The center is a national leader in comprehensive gastric cancer treatment, minimally invasive surgery, and translational research. It established the first minimally invasive surgery department for gastrointestinal tumors in China and maintains a high-quality research team.
A leading center for radiopharmaceutical research, development, and clinical translation in China
The Department of Nuclear Medicine at Peking University Cancer Hospital is a Key Laboratory of the National Medical Products Administration (NMPA). It holds a leading position in China in the research and development of targeted molecular probes, multimodal molecular imaging, and targeted radiopharmaceutical therapy.
Consistently ranked highly in the Fudan University Hospital Specialist Reputation Rankings
Established in 1976, the department successfully developed China's first linear accelerator. Equipped with advanced radiotherapy equipment, it maintains a leading position in China for the precise radiotherapy and comprehensive treatment of head and neck, thoracic, and abdominal tumors, as well as lymphomas. It is a key discipline integrating clinical care, education, and research.
A leading center for melanoma and soft tissue sarcoma diagnosis, treatment, and research in China
This department specializes in the medical treatment and translational research of melanoma and soft tissue sarcoma. It is a leader in China in targeted therapy, immunotherapy, and personalized comprehensive treatment, and has led the development of multiple editions of the Chinese guidelines for melanoma diagnosis and treatment.
Ranked among the top nationwide in oncology by the Fudan University Hospital Specialist Reputation Ranking.
The Department of Medical Oncology at Peking University Cancer Hospital is a leading comprehensive treatment center for malignant tumors in China. It provides targeted therapy and immunotherapy for gastrointestinal tumors, lymphoma, melanoma, and other cancers. The department is dedicated to establishing national guidelines for oncology diagnosis and treatment, with comprehensive capabilities at the forefront both in China and internationally.
National Clinical Key Specialty and a pioneer in interventional oncology in China.
The center is one of the earliest institutions in China to offer interventional oncology treatments. It is a leading facility in China and maintains advanced international standards in minimally invasive interventional therapy, radioactive seed implantation, chemical ablation, and comprehensive interventional treatment for liver cancer, lung cancer, and metastatic tumors.
National Key Clinical Specialty Construction Project
The Department of Pathology at Peking University Cancer Hospital is a National Key Clinical Specialty. It is a leading center in China for the complex pathological diagnosis of gastrointestinal tumors, breast cancer, lymphoma, and malignant melanoma. The department issues tens of thousands of pathology reports annually, supported by extensive clinical expertise.
Key information
Established
1976
Beds
801+
Annual outpatients
750K+
Annual surgeries
17K+
Language support
Chinese, English, Japanese, Russian
Accreditations
Travel & support
Multilingual Services
The International Medical Center provides professional medical translation in English, Japanese, and other languages to ensure clear communication.
Green Channel
Priority scheduling for appointments, examinations, and admissions is available for international patients to minimize waiting times.
Visa Assistance
Provision of invitation letters and necessary medical documentation to support medical visa applications.